JP2012517969A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012517969A5 JP2012517969A5 JP2011549494A JP2011549494A JP2012517969A5 JP 2012517969 A5 JP2012517969 A5 JP 2012517969A5 JP 2011549494 A JP2011549494 A JP 2011549494A JP 2011549494 A JP2011549494 A JP 2011549494A JP 2012517969 A5 JP2012517969 A5 JP 2012517969A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- hydrogen
- composition according
- hair
- alopecia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims description 18
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 201000004384 Alopecia Diseases 0.000 claims 5
- 231100000360 alopecia Toxicity 0.000 claims 4
- 230000003779 hair growth Effects 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- DQUOOKMLOSPCLZ-LLVKDONJSA-N (2r)-3-(4-acetamidophenyl)-2-methoxypropanoic acid Chemical compound CO[C@@H](C(O)=O)CC1=CC=C(NC(C)=O)C=C1 DQUOOKMLOSPCLZ-LLVKDONJSA-N 0.000 claims 1
- 206010047642 Vitiligo Diseases 0.000 claims 1
- 208000004631 alopecia areata Diseases 0.000 claims 1
- 230000003698 anagen phase Effects 0.000 claims 1
- 230000035614 depigmentation Effects 0.000 claims 1
- 208000024963 hair loss Diseases 0.000 claims 1
- 230000003676 hair loss Effects 0.000 claims 1
- 230000000284 resting effect Effects 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09425056.0 | 2009-02-16 | ||
| EP09425056 | 2009-02-16 | ||
| US17906209P | 2009-05-18 | 2009-05-18 | |
| US61/179,062 | 2009-05-18 | ||
| US28746109P | 2009-12-17 | 2009-12-17 | |
| US61/287,461 | 2009-12-17 | ||
| PCT/EP2010/000939 WO2010091894A2 (en) | 2009-02-16 | 2010-02-16 | Methods of treating hair related conditions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012517969A JP2012517969A (ja) | 2012-08-09 |
| JP2012517969A5 true JP2012517969A5 (enExample) | 2014-11-06 |
| JP5645851B2 JP5645851B2 (ja) | 2014-12-24 |
Family
ID=42562114
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011549492A Active JP5715070B2 (ja) | 2009-02-16 | 2010-02-16 | アルキルアミド化合物およびその使用 |
| JP2011549494A Expired - Fee Related JP5645851B2 (ja) | 2009-02-16 | 2010-02-16 | 毛に関する状態を処置する方法 |
| JP2014158397A Active JP5820030B2 (ja) | 2009-02-16 | 2014-08-04 | アルキルアミド化合物およびその使用 |
| JP2015074798A Pending JP2015155427A (ja) | 2009-02-16 | 2015-04-01 | アルキルアミド化合物およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011549492A Active JP5715070B2 (ja) | 2009-02-16 | 2010-02-16 | アルキルアミド化合物およびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014158397A Active JP5820030B2 (ja) | 2009-02-16 | 2014-08-04 | アルキルアミド化合物およびその使用 |
| JP2015074798A Pending JP2015155427A (ja) | 2009-02-16 | 2015-04-01 | アルキルアミド化合物およびその使用 |
Country Status (25)
| Country | Link |
|---|---|
| US (11) | US8796334B2 (enExample) |
| EP (4) | EP2805746B1 (enExample) |
| JP (4) | JP5715070B2 (enExample) |
| KR (2) | KR101776337B1 (enExample) |
| CN (3) | CN102316931B (enExample) |
| AR (1) | AR080596A1 (enExample) |
| AU (2) | AU2010213093B2 (enExample) |
| BR (2) | BRPI1011226B1 (enExample) |
| CA (2) | CA2752623C (enExample) |
| CY (2) | CY1119225T1 (enExample) |
| DK (2) | DK2396081T3 (enExample) |
| EA (2) | EA020198B1 (enExample) |
| ES (3) | ES2630044T3 (enExample) |
| HR (2) | HRP20170936T1 (enExample) |
| HU (2) | HUE050267T2 (enExample) |
| IL (2) | IL214664A (enExample) |
| LT (2) | LT2396081T (enExample) |
| MX (3) | MX381002B (enExample) |
| NZ (2) | NZ595080A (enExample) |
| PL (1) | PL2396081T3 (enExample) |
| PT (3) | PT2396081T (enExample) |
| SI (2) | SI2805746T1 (enExample) |
| UA (2) | UA105037C2 (enExample) |
| WO (2) | WO2010091894A2 (enExample) |
| ZA (1) | ZA201106256B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4805556A (en) | 1988-01-15 | 1989-02-21 | Union Carbide Corporation | Reactor system and method for forming uniformly large-diameter polycrystalline rods by the pyrolysis of silane |
| ITRM20050390A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| ITRM20050389A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| UA107562C2 (uk) | 2008-12-05 | 2015-01-26 | Спосіб лікування псоріазу | |
| EP2805746B1 (en) | 2009-02-16 | 2020-05-06 | Nogra Pharma Limited | Alkylamido compounds and uses thereof |
| ES2711100T3 (es) * | 2011-03-07 | 2019-04-30 | Celgene Corp | Métodos para tratar enfermedades usando compuestos isoindolina |
| JP6301844B2 (ja) * | 2012-02-09 | 2018-03-28 | ノグラ ファーマ リミテッド | 線維症の処置方法 |
| AU2013248397A1 (en) | 2012-04-18 | 2014-10-02 | Nogra Pharma Limited | Methods of treating lactose intolerance |
| NZ705389A (en) * | 2012-09-13 | 2018-08-31 | Nogra Pharma Ltd | Methods of treating hair related conditions |
| EP2897603A1 (en) * | 2012-09-13 | 2015-07-29 | Nogra Pharma Limited | Methods of inhibiting hair growth |
| KR101441278B1 (ko) * | 2013-11-17 | 2014-09-17 | 한규나 | 머리카락 분말을 이용한 재활용 방법 |
| JP6371520B2 (ja) * | 2013-12-26 | 2018-08-08 | 日本メナード化粧品株式会社 | 皮脂合成促進剤 |
| AU2016246688B2 (en) | 2015-04-06 | 2020-11-12 | The Trustees Of The University Of Pennsylvania | Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject |
| WO2017210600A1 (en) * | 2016-06-03 | 2017-12-07 | The Scripps Research Institute | Compositions and methods of modulating immune response |
| WO2020152350A1 (en) * | 2019-01-25 | 2020-07-30 | Nogra Pharma Limited | Compositions for use in preventing acne |
| SI3921299T1 (sl) * | 2019-02-08 | 2025-03-31 | Nogra Pharma Limited | Postopek izdelave 3-(4'-aminofenil)-2-metoksipropionske kisline in njenih analogov in vmesnih proizvodov |
| JP6925072B1 (ja) * | 2020-12-07 | 2021-08-25 | 株式会社Dr.Cherry | 毛髪改善のための組成物 |
Family Cites Families (110)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB767788A (en) | 1953-12-28 | 1957-02-06 | Schering Corp | Polyiodinated phenyl fatty acid compounds and process for their manufacture |
| US3211610A (en) | 1961-09-29 | 1965-10-12 | Merck & Co Inc | Benzoic acid ester derivatives for treating coccidiosis and method of using same |
| US3444232A (en) | 1966-05-18 | 1969-05-13 | Squibb & Sons Inc | O-alkyl or phenylalkyl benzohydroxamic acids |
| GB1359560A (en) | 1972-02-25 | 1974-07-10 | Merck & Co Inc | Preparation of pyrrylsalicylic acid |
| US4036951A (en) | 1973-03-12 | 1977-07-19 | Synergistics, Inc. | Ultra-violet filtration with certain aminosalicylic acid esters |
| FR2440353A1 (fr) | 1978-11-03 | 1980-05-30 | Science Union & Cie | Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament |
| US4348223A (en) | 1980-12-05 | 1982-09-07 | Ppg Industries, Inc. | N-Alkyl-N-[3-(alkoxyalkyl)phenyl]-2-haloacetamide herbicides |
| EP0055689B1 (de) | 1980-12-22 | 1984-07-04 | Schering Aktiengesellschaft | In 3-Stellung substituierte 2,4,6-trihalogenierte Benzamide und deren Salze, deren Herstellung und Verwendung als Ersatzstoffe für natürliche Süssstoffe sowie Süssungsmittel auf Basis dieser Verbindungen |
| JPS58194814A (ja) | 1982-05-11 | 1983-11-12 | Nippon Shinyaku Co Ltd | 免疫調節作用を有する薬剤 |
| IL69282A (en) | 1982-09-02 | 1988-06-30 | Euro Celtique Sa | Method for the carboxylation of potassium phenoxide with carbon dioxide |
| GB8302708D0 (en) | 1983-02-01 | 1983-03-02 | Efamol Ltd | Pharmaceutical and dietary composition |
| DE3786452T2 (de) | 1987-02-05 | 1993-10-21 | Kureha Chemical Ind Co Ltd | Benzylether-Verbindungen und Verfahren zu ihrer Herstellung. |
| US4933330A (en) * | 1987-04-01 | 1990-06-12 | Dak-Laboratoriet | Benzoic acid derivatives and use thereof |
| ATE113209T1 (de) | 1988-05-05 | 1994-11-15 | Tillotts Pharma Ag | Verwendung von 5-amino-salicylsäure für die behandlung von hautkrankheiten. |
| US5519014A (en) | 1990-10-22 | 1996-05-21 | Borody; Thomas J. | Treatment of non-inflammatory and non-infectious bowel disorders |
| WO1992006690A1 (en) | 1990-10-22 | 1992-04-30 | Borody Thomas J | Treatment of non-inflammatory and non-infectious bowel disorders |
| US5262549A (en) | 1991-05-30 | 1993-11-16 | Polaroid Corporation | Benzpyrylium dyes, and processes for their preparation and use |
| US5302751A (en) | 1992-01-21 | 1994-04-12 | Ethyl Corporation | Profen resolution |
| ES2166359T3 (es) | 1992-03-17 | 2002-04-16 | Fujisawa Pharmaceutical Co | Derivado de depsipeptido, su produccion y uso. |
| WO1994000135A1 (en) | 1992-06-30 | 1994-01-06 | Shapiro Howard K | Composition containing amine and amine-related derivatives of benzoic acid and uses therefor including treating inflammatory diseases |
| US5594151A (en) | 1994-01-28 | 1997-01-14 | Prolinx, Inc. | Phenylboronic acid complexing reagents derived from aminosalicylic acid |
| CA2190107A1 (en) | 1994-05-11 | 1995-11-23 | Howard K. Shapiro | Compositions for treatment of chronic inflammatory diseases |
| US5594015A (en) | 1994-06-22 | 1997-01-14 | Regents Of The University Of California | Thiazolidine derivatives for the treatment of psoriasis |
| HUP9900309A3 (en) | 1995-03-28 | 1999-11-29 | Janssen Pharmaceutica Nv | Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases |
| GB9600464D0 (en) | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| GB9617001D0 (en) | 1996-08-13 | 1996-09-25 | Tillotts Pharma Ag | Oral composition |
| DE19647582A1 (de) | 1996-11-18 | 1998-05-20 | Hoechst Ag | Verfahren zur Herstellung von aromatischen Olefinen mittels Katalyse durch Palladaphosphacyclobutane |
| WO1998043081A1 (en) | 1997-03-26 | 1998-10-01 | Ligand Pharmaceuticals Incorporated | Treatment of gastrointestinal disease with ppar modulators |
| WO1999005161A1 (en) | 1997-07-25 | 1999-02-04 | Ligand Pharmaceuticals Incorporated | HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR |
| AU9002798A (en) | 1997-09-19 | 1999-04-12 | Ono Pharmaceutical Co. Ltd. | Fused or nonfused benzene compounds |
| US7015249B1 (en) | 1997-12-12 | 2006-03-21 | Purdue Research Foundation | Methods and compositions for treating diabetes |
| FR2773075B1 (fr) | 1997-12-31 | 2000-05-05 | Cird Galderma | Utilisation d'activateurs de ppar-gamma en dermatologie |
| US6114382A (en) | 1998-11-11 | 2000-09-05 | Moretti; Itagiba G. | Methods for treating inflammatory bowel disease |
| US6326364B1 (en) | 1999-02-08 | 2001-12-04 | Cedars-Sinai Medical Center | Use of 5-aminosalicylates as antimicrobial agents |
| FR2791671B1 (fr) * | 1999-04-01 | 2001-05-11 | Oreal | Nouveaux composes derives d'esters d'acide benzoique, composition les comprenant et utilisation |
| GB9908647D0 (en) | 1999-04-15 | 1999-06-09 | Smithkline Beecham Plc | Novel compounds |
| US20040034067A1 (en) | 1999-04-15 | 2004-02-19 | Macphee Colin Houston | Novel method of treatment |
| GB9914371D0 (en) | 1999-06-18 | 1999-08-18 | Smithkline Beecham Plc | Novel compounds |
| TWI262185B (en) | 1999-10-01 | 2006-09-21 | Eisai Co Ltd | Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives |
| AU7995300A (en) | 1999-10-05 | 2001-05-10 | Bethesda Pharmaceuticals, Inc. | Dithiolane derivatives |
| US7736661B1 (en) | 2000-03-07 | 2010-06-15 | Avon Products, Inc | Method of treating skin conditions |
| CA2656216C (en) | 2000-04-19 | 2012-01-24 | Neurotech Co., Ltd. | Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| SI1285908T1 (sl) * | 2000-05-29 | 2008-12-31 | Kyorin Seiyaku Kk | Substituirani fenilpropionski kislinski derivati |
| US7049342B2 (en) | 2000-05-29 | 2006-05-23 | Kyorin Pharmaceutical Co., Ltd. | Substituted phenylpropionic acid derivatives |
| DE60115465T2 (de) | 2000-08-29 | 2006-08-03 | Nobex Corp. | Immunoregulierende verbindungen, deren derivate und ihre verwendung |
| AU2002222574A1 (en) * | 2000-12-05 | 2002-06-18 | Kyorin Pharmaceutical Co. Ltd. | Substituted carboxylic acid derivatives |
| FR2822955B1 (fr) | 2001-03-27 | 2003-10-03 | Chru Lille | Methode de diagnostic de maladies inflammatoires chroniques de l'intestin |
| US7312247B2 (en) | 2001-03-27 | 2007-12-25 | Errant Gene Therapeutics, Llc | Histone deacetylase inhibitors |
| JP2004528329A (ja) | 2001-04-18 | 2004-09-16 | メルク エンド カムパニー インコーポレーテッド | 炎症を処置するためのＰＰＡＲα〜γのリガンドまたはアゴニスト |
| CA2354921A1 (en) | 2001-05-24 | 2002-11-24 | Yasuo Konishi | Drug evolution: drug design at hot spots |
| CN1589258A (zh) | 2001-10-16 | 2005-03-02 | 雷迪实验室有限公司 | 新的β－苯基－α－氧取代的丙酸衍生物,它的制备方法和它们制备药学上重要的化合物的应用 |
| WO2003043569A2 (en) | 2001-11-16 | 2003-05-30 | Nutrition 21, Inc. | Trans-10, cis-12 conjugated linoleic acid isomer for the treatment of diseases |
| GB0127916D0 (en) | 2001-11-21 | 2002-01-16 | Rowett Res Inst | Method |
| AU2002343094A1 (en) | 2001-11-26 | 2003-06-10 | Arachnova Therapeutics Ltd. | Use of ppar activators for the treatment of pulmonary fibrosis |
| UA82835C2 (en) * | 2001-12-03 | 2008-05-26 | Reddys Lab Ltd Dr | ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon |
| US20030113815A1 (en) | 2001-12-19 | 2003-06-19 | Pfizer Inc. | Canine peroxisome proliferator activated receptor gamma |
| WO2003053974A1 (en) | 2001-12-21 | 2003-07-03 | Dr. Reddy's Laboratories Ltd. | Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| US20030220374A1 (en) | 2002-01-14 | 2003-11-27 | Pharmacia Corporation | Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors |
| US20040115127A1 (en) | 2002-04-12 | 2004-06-17 | Wright Samuel D. | Ppar-alpha-gamma ligands or agonists for the treatment of inflammation |
| US8492438B2 (en) | 2002-04-26 | 2013-07-23 | Asan Laboratories Company (Cayman), Limited | Treatment skin disorders |
| US20040009956A1 (en) | 2002-04-29 | 2004-01-15 | Dehua Pei | Inhibition of protein tyrosine phosphatases and SH2 domains by a neutral phosphotyrosine mimetic |
| DE10250080A1 (de) | 2002-10-25 | 2004-05-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| US20060159648A1 (en) | 2003-02-17 | 2006-07-20 | Davis Adrian F | Novel therapeutic method and compositions for topical administration |
| GB0303609D0 (en) | 2003-02-17 | 2003-03-19 | Glaxo Group Ltd | Novel therapeutic method and compositions |
| JPWO2004082715A1 (ja) | 2003-03-20 | 2006-06-22 | エーザイ株式会社 | 炎症性腸疾患治療剤としての併用医薬 |
| JP5198768B2 (ja) | 2003-07-21 | 2013-05-15 | メルク セローノ ソシエテ アノニム | アルキニルアリールカルボキサミド |
| UA60954C2 (en) | 2003-07-25 | 2006-03-15 | Subsidiary Entpr With Foreign | Method for measuring conductivity of electrolyte by a contactless measuring transducer |
| GB2422782A (en) | 2003-10-21 | 2006-08-09 | Inspire Pharmaceuticals Inc | Non-nucleotide compositions and method for treating pain |
| US20070093476A1 (en) | 2003-10-28 | 2007-04-26 | Bhunia Debnath | Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them |
| FR2862870A1 (fr) | 2003-12-01 | 2005-06-03 | Galderma Res & Dev | Utilisation d'activateurs de recepteurs ppar en cosmetique et dermatologie. |
| EP1691806A2 (en) | 2003-12-03 | 2006-08-23 | Smithkline Beecham Corporation | Novel therapeutic method and compositions |
| CA2553775A1 (en) | 2004-01-20 | 2005-08-11 | Richard F. Harty | Compositions and methods of treatment for inflammatory diseases |
| WO2005084658A1 (en) * | 2004-03-04 | 2005-09-15 | Arakis Ltd. | Derivatives of actarit and their therapeutic use |
| US20050277693A1 (en) | 2004-06-10 | 2005-12-15 | Dr. Reddy's Laboratories Limited | Basic salts and monohydrates of certain alpha, beta-propionic acid derivative |
| PE20060594A1 (es) | 2004-09-09 | 2006-08-18 | Novartis Ag | Composicion farmaceutica que contiene un agonista de ppar |
| AU2005289453A1 (en) | 2004-09-27 | 2006-04-06 | Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services, National Institutes of Health | Modulating MxA expression |
| US20060286046A1 (en) | 2005-01-05 | 2006-12-21 | Haber C Andrew | Skin care compositions |
| EP1719543A1 (en) | 2005-05-04 | 2006-11-08 | Asan Labs., Ltd. | Use of histone deacetylase inhibitors for the treatment of gastrointestinal distress |
| US20060270635A1 (en) | 2005-05-27 | 2006-11-30 | Wallace John L | Derivatives of 4- or 5-aminosalicylic acid |
| ITRM20050390A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| ITRM20050389A1 (it) * | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| DE102005061472A1 (de) | 2005-12-22 | 2007-07-05 | Saltigo Gmbh | Verfahren zur Herstellung von enantiomerenangereicherten 2-Alkoxy-3-phenylpropionsäuren |
| WO2007096148A1 (en) | 2006-02-23 | 2007-08-30 | Lipid Nutrition B.V. | Immunoregulation |
| US7645801B2 (en) | 2007-01-29 | 2010-01-12 | Alaven Pharmaceutical Llc | Reduced irritant enema for treatment of inflammatory bowel disease (IBD) |
| IE20070129A1 (en) * | 2007-02-28 | 2008-12-24 | Giuliani Int Ltd | Ppar-gamma agonists stimulate enteric defensin expression |
| US8796282B2 (en) | 2007-03-28 | 2014-08-05 | Case Western Reserve University | Method of treating dermatological disorders |
| WO2009025854A1 (en) | 2007-08-22 | 2009-02-26 | Burnham Institute For Medical Research | Smips: small molecule inhibitors of p27 depletion in cancers and other proliferative diseases |
| ITMI20072429A1 (it) | 2007-12-24 | 2009-06-25 | Giuliani Int Ltd | Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca |
| US8030520B2 (en) | 2008-03-31 | 2011-10-04 | Saltigo Gmbh | Process for preparing organic compounds by a transition metal-catalysed cross-coupling reaction of an aryl-X, heteroaryl-X, cycloalkenyl-X or alkenyl-X compound with an alkyl, alkenyl, cycloalkyl or cycloalkenyl halide |
| UA107562C2 (uk) | 2008-12-05 | 2015-01-26 | Спосіб лікування псоріазу | |
| EP2805746B1 (en) | 2009-02-16 | 2020-05-06 | Nogra Pharma Limited | Alkylamido compounds and uses thereof |
| EP2298321A1 (en) | 2009-08-26 | 2011-03-23 | Nordic Pharma | Novel pharmaceutical compositions for treating IBD |
| EP2731605A4 (en) | 2011-07-15 | 2015-02-25 | Sla Pharma Ag | PHARMACEUTICAL COMPOSITIONS FOR RECTAL ADMINISTRATION |
| MX351878B (es) | 2011-10-17 | 2017-11-01 | The Regents Of Univ Of California | Metodos para evaluar la calidad del repelente de materiales organicos y metodos y composiciones para repeler artropodos. |
| EP2773378B1 (en) | 2011-10-31 | 2016-08-10 | Larsen, Claus Selch | Prodrugs of non-steroid anti-inflammatory agents (nsaids) |
| JP6301844B2 (ja) | 2012-02-09 | 2018-03-28 | ノグラ ファーマ リミテッド | 線維症の処置方法 |
| AU2013248397A1 (en) | 2012-04-18 | 2014-10-02 | Nogra Pharma Limited | Methods of treating lactose intolerance |
| JP6096179B2 (ja) | 2012-05-10 | 2017-03-15 | 国立大学法人岩手大学 | ラクターゼ活性を有するタンパク質、該タンパク質をコードする遺伝子、該遺伝子を含有する組み換えベクター、形質転換体、及びその製造方法並びに用途 |
| US9013997B2 (en) | 2012-06-01 | 2015-04-21 | Broadcom Corporation | System for performing distributed data cut-through |
| IN2014DN10214A (enExample) | 2012-06-01 | 2015-08-07 | Nogra Pharma Ltd | |
| CN110664816A (zh) | 2012-06-07 | 2020-01-10 | 佐治亚州立大学研究基金会公司 | Seca抑制剂以及其制备和使用方法 |
| NZ705389A (en) | 2012-09-13 | 2018-08-31 | Nogra Pharma Ltd | Methods of treating hair related conditions |
| EP2897603A1 (en) | 2012-09-13 | 2015-07-29 | Nogra Pharma Limited | Methods of inhibiting hair growth |
| WO2014154683A1 (en) | 2013-03-26 | 2014-10-02 | Lipid Therapeutics Gmbh | Pharmaceutical formulation comprising phosphatidylcholine for the treatment of ulcerative colitis |
| CN105566153B (zh) | 2014-10-14 | 2019-05-31 | 中国医学科学院药物研究所 | 偶氮苯衍生物及其制法和药物组合物与用途 |
| WO2016154730A1 (en) | 2015-04-02 | 2016-10-06 | University Health Network | Gut anti-inflammatory agents for regulation of high blood glucose levels |
| JP6798075B2 (ja) | 2015-06-15 | 2020-12-09 | エヌエムディー ファーマ エー／エス | 神経筋障害を処置するのにおける使用のための化合物 |
| WO2017046343A1 (en) | 2015-09-17 | 2017-03-23 | Nogra Pharma Limited | Compositions for rectal administration in the treatment of ulcerative colitis and methods of using same |
| WO2017093444A1 (en) | 2015-12-01 | 2017-06-08 | Nogra Pharma Limited | Compositions for oral administration in the treatment of inflammatory bowel disease |
| WO2017144725A1 (en) | 2016-02-26 | 2017-08-31 | Nogra Pharma Limited | Methods of treating lactose intolerance |
-
2010
- 2010-02-16 EP EP14170446.0A patent/EP2805746B1/en active Active
- 2010-02-16 CN CN201080007816.7A patent/CN102316931B/zh active Active
- 2010-02-16 CA CA2752623A patent/CA2752623C/en active Active
- 2010-02-16 BR BRPI1011226-0A patent/BRPI1011226B1/pt not_active IP Right Cessation
- 2010-02-16 JP JP2011549492A patent/JP5715070B2/ja active Active
- 2010-02-16 NZ NZ595080A patent/NZ595080A/xx not_active IP Right Cessation
- 2010-02-16 HR HRP20170936TT patent/HRP20170936T1/hr unknown
- 2010-02-16 BR BRPI1008752-4A patent/BRPI1008752B1/pt active IP Right Grant
- 2010-02-16 WO PCT/EP2010/000939 patent/WO2010091894A2/en not_active Ceased
- 2010-02-16 DK DK10708105.1T patent/DK2396081T3/en active
- 2010-02-16 US US13/201,790 patent/US8796334B2/en not_active Expired - Fee Related
- 2010-02-16 CN CN201080007823.7A patent/CN102316932B/zh not_active Expired - Fee Related
- 2010-02-16 DK DK14170446.0T patent/DK2805746T3/da active
- 2010-02-16 SI SI201032023T patent/SI2805746T1/sl unknown
- 2010-02-16 EP EP10708105.1A patent/EP2396081B1/en active Active
- 2010-02-16 JP JP2011549494A patent/JP5645851B2/ja not_active Expired - Fee Related
- 2010-02-16 ES ES10708105.1T patent/ES2630044T3/es active Active
- 2010-02-16 SI SI201031492T patent/SI2396081T1/sl unknown
- 2010-02-16 MX MX2014008192A patent/MX381002B/es unknown
- 2010-02-16 AU AU2010213093A patent/AU2010213093B2/en active Active
- 2010-02-16 EP EP20172608.0A patent/EP3744398A1/en active Pending
- 2010-02-16 HU HUE14170446A patent/HUE050267T2/hu unknown
- 2010-02-16 WO PCT/EP2010/000935 patent/WO2010091892A2/en not_active Ceased
- 2010-02-16 HU HUE10708105A patent/HUE032999T2/hu unknown
- 2010-02-16 KR KR1020117021457A patent/KR101776337B1/ko not_active Expired - Fee Related
- 2010-02-16 ES ES10708489T patent/ES2429143T3/es active Active
- 2010-02-16 CA CA2752626A patent/CA2752626C/en not_active Expired - Fee Related
- 2010-02-16 PT PT107081051T patent/PT2396081T/pt unknown
- 2010-02-16 NZ NZ595076A patent/NZ595076A/xx unknown
- 2010-02-16 AR ARP100100447A patent/AR080596A1/es active IP Right Grant
- 2010-02-16 LT LTEP10708105.1T patent/LT2396081T/lt unknown
- 2010-02-16 EA EA201171062A patent/EA020198B1/ru not_active IP Right Cessation
- 2010-02-16 PT PT141704460T patent/PT2805746T/pt unknown
- 2010-02-16 EA EA201171063A patent/EA020856B1/ru not_active IP Right Cessation
- 2010-02-16 CN CN201410526159.7A patent/CN104666288B/zh active Active
- 2010-02-16 PL PL10708105T patent/PL2396081T3/pl unknown
- 2010-02-16 ES ES14170446T patent/ES2806691T3/es active Active
- 2010-02-16 PT PT107084899T patent/PT2396082E/pt unknown
- 2010-02-16 LT LTEP14170446.0T patent/LT2805746T/lt unknown
- 2010-02-16 EP EP10708489.9A patent/EP2396082B1/en not_active Not-in-force
- 2010-02-16 KR KR1020117021458A patent/KR101800901B1/ko active Active
- 2010-02-16 US US13/201,786 patent/US8754127B2/en active Active
- 2010-02-16 AU AU2010213095A patent/AU2010213095B2/en not_active Ceased
- 2010-02-16 UA UAA201111058A patent/UA105037C2/uk unknown
- 2010-02-16 MX MX2011008601A patent/MX2011008601A/es active IP Right Grant
- 2010-02-16 UA UAA201111055A patent/UA109525C2/ru unknown
- 2010-02-16 MX MX2011008602A patent/MX2011008602A/es active IP Right Grant
-
2011
- 2011-08-15 IL IL214664A patent/IL214664A/en active IP Right Grant
- 2011-08-15 IL IL214665A patent/IL214665A/en active IP Right Grant
- 2011-08-25 ZA ZA2011/06256A patent/ZA201106256B/en unknown
-
2014
- 2014-04-17 US US14/255,255 patent/US9511041B2/en active Active
- 2014-06-25 US US14/314,738 patent/US20150148418A1/en not_active Abandoned
- 2014-08-04 JP JP2014158397A patent/JP5820030B2/ja active Active
-
2015
- 2015-04-01 JP JP2015074798A patent/JP2015155427A/ja active Pending
- 2015-12-15 US US14/969,939 patent/US9901557B2/en not_active Expired - Fee Related
-
2016
- 2016-10-28 US US15/337,707 patent/US10137101B2/en active Active
-
2017
- 2017-06-28 CY CY20171100678T patent/CY1119225T1/el unknown
-
2018
- 2018-01-16 US US15/872,436 patent/US10398667B2/en not_active Expired - Fee Related
- 2018-10-02 US US16/149,524 patent/US20190269637A1/en not_active Abandoned
-
2019
- 2019-07-18 US US16/515,532 patent/US10959970B2/en not_active Expired - Fee Related
-
2020
- 2020-01-03 US US16/733,349 patent/US20200383942A1/en not_active Abandoned
- 2020-07-29 HR HRP20201184TT patent/HRP20201184T1/hr unknown
- 2020-07-29 CY CY20201100702T patent/CY1123213T1/el unknown
-
2021
- 2021-12-01 US US17/539,447 patent/US20220354809A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012517969A5 (enExample) | ||
| JP2014506907A5 (enExample) | ||
| JP2015537020A5 (enExample) | ||
| WO2010097480A3 (en) | Menthyl carbamate compounds as skin and/or hair lightening actives | |
| WO2012007877A3 (en) | N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels | |
| JP2013534248A5 (enExample) | ||
| WO2007110415A3 (en) | Use of diacetyl trimers and cosmetic or therapeutic formulations containing these compounds | |
| JP2014507455A5 (enExample) | ||
| JP2009519993A5 (enExample) | ||
| RU2014105624A (ru) | Соединения индазола, способ их применения и фармацевтическая композиция | |
| WO2012122340A8 (en) | Soluble guanylate cyclase activators | |
| JP2011509949A5 (enExample) | ||
| JP2004534774A5 (enExample) | ||
| MX2008002152A (es) | Formulacion de bis(tio-hidrazida amida. | |
| SI2205244T1 (sl) | Postopki dajanja N-(5-terc.-butil-izoksazol-3-il)-N'-(4-(7-(2-morfolin- 4-il-etoksi-)imidazo-2,1-b)-(1,3)-benzotiazol-2-il)-fenil)sečnine za zdravljenje proliferativne bolezni | |
| JP2014525394A5 (enExample) | ||
| WO2008012782A3 (en) | Labelled analogues of halobenzamides as radiopharmaceuticals | |
| FI3365321T3 (fi) | Solabegron-Zwitterioni ja sen käyttöjä | |
| RU2015143409A (ru) | Композиции для местного нанесения, содержащие биматопрост, и способы стимуляции роста волос с их помощью | |
| JP2014530818A5 (enExample) | ||
| WO2012161497A3 (ko) | 보습능이 우수한 펩타이드 유도체 및 이의 용도 | |
| JP2015522037A5 (enExample) | ||
| JP2010530002A5 (enExample) | ||
| RU2016134130A (ru) | ПИРАЗОЛО[1,5-а]ПИРИМИДИНЫ В КАЧЕСТВЕ ПРОТИВОВИРУСНЫХ СОЕДИНЕНИЙ | |
| WO2012026813A3 (en) | Analogs of geranylgeranylacetone and uses thereof |